Parteek Prasher, Tanisqa Mall & Mousmee Sharma. (2023) Cyclic carbamates in medicine: A clinical perspective. Drug Development Research 84:3, pages 397-405.
Crossref
Maciej Gawlik, Jakub Trawiński & Robert Skibiński. (2018) Imitation of phase I metabolism reactions of MAO-A inhibitors by titanium dioxide photocatalysis. European Journal of Pharmaceutical Sciences 114, pages 391-400.
Crossref
Soumaya Slama & Rafâa Besbes. (2014) Stereoselective synthesis of erythro-β-chloroamines and their conversion into functionalized trans-oxazolidin-2-ones. Tetrahedron 70:32, pages 4732-4737.
Crossref
Neha Pandit, Rajeev K. Singla & Birendra Shrivastava. (2012) Current Updates on Oxazolidinone and Its Significance. International Journal of Medicinal Chemistry 2012, pages 1-24.
Crossref
R Vistelle, D Lamiable, M Zinsou, A Leon & M Wiczewski. (1992) Toloxatone pharmacokinetics in the plasma and cerebrospinal fluid of the rabbit. Journal of Pharmacy and Pharmacology 44:2, pages 124-126.
Crossref
M. Gerlach, P. Riederer, J. R. Martin, R. Amrein, P. C. Waldmeier, R. Kettler, E. Borroni, A. Cesura, E. Grünblatt, K. Jorga, J. G. Richards, M. Da Prada, G. Laux, T. Becker, U. Müller, U. Müller, G. Laux, P. R. Bieck, M. P. Schmauss & T. W. Guentert. 2002. Neuro-Psychopharmaka Ein Therapie-Handbuch. Neuro-Psychopharmaka Ein Therapie-Handbuch
437
557
.
Matthieu L. Kaltenbach, Richard Vistelle, Guillaume Hoizey, Denis Larniable & Liliane Zbierski. (2006) Effect of Acute Ethanol Administration on Toloxatone Pharmacokinetics in Rabbits. Alcoholism: Clinical and Experimental Research 23:5, pages 885-890.
Crossref
M. Gerlach, P. Riederer, M. P. Schoerlin, T. W. Guentert, P. Waldmeier, R. Kettler, A. Cesura, J. G. Richards, M. Da Prada, G. Laux, T. Becker, P. R. Bieck & M. Schmauß. 1993. Neuro-Psychopharmaka. Neuro-Psychopharmaka
269
354
.
S. Mitsuhashi, T. Kojima, N. Nakanishi, T. Fujimoto, O. Goto, S. Miyusaki, T. Uematsu, M. Nakashima, Y. Asahina, T. Ishisaki, S. Susue, K. Hirai, K. Hoshino, J. Shimada, S. Hori, V. K. Singh, A. Pletscher, M. D. Tricklebank, L. J. Bristow & P. H. HutsonAndrea M. Cesura & Alfred Pletscher. 1992. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques
171
297
.
R. Vistelle, D. Lamiable & M. Zinzou. (1989) Simple high-performance liquid chromatographic method for the measurement of toloxatone in rabbit cerebrospinal fluid and plasma. Journal of Chromatography B: Biomedical Sciences and Applications 490, pages 387-394.
Crossref
S. Vajta, J.P. Le Moing & V. Rovei. (1984) Reversed-phase high-performance liquid chromatographic separation of 14C-labelled toloxatone and its metabolites. Journal of Chromatography B: Biomedical Sciences and Applications 311, pages 329-337.
Crossref
S. Vajta, J.P. Le Moing & V. Rovei. (1983) Gas—liquid chromatographic determination of toloxatone in human plasma. Journal of Chromatography B: Biomedical Sciences and Applications 274, pages 139-148.
Crossref
Roger M. Pinder. 1980.
1
11
.
